Cafepharma Today

January 27 2025 - Sage rejects Biogen's $469 million takeover offer, says offer undervalues company
Sage rejects Biogen's $469 million takeover offer, says offer undervalues company
Metsera eyes $289M IPO to fund phase 3 weight loss trial
Biogen, Eisai win nod for monthly Leqembi maintenance amid stagnant sales
Sara Brenner, FDA device official, named agency’s acting head
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Merck's Charm Offensive
CNBC
Thursday, August 28, 2008 - 11:10am
tags:
BDSI gets good news on drug, though approval is delayed
Bizjournals.com
Thursday, August 28, 2008 - 10:54am
tags:
J&J to appeal Razadyne patent ruling
Marketwatch
Thursday, August 28, 2008 - 10:53am
tags:
Ortho-McNeil Neurologics to Appeal Patent Ruling on RAZADYNE
Yahoo/AP
Thursday, August 28, 2008 - 9:21am
tags:
Report: Medicare Pays Too Much for Some New Generics
WSJ Online
Thursday, August 28, 2008 - 8:09am
tags:
Pfizer Is Worth Another Look
Seeking Alpha
Thursday, August 28, 2008 - 8:08am
tags:
Amgen to Stop Offering Discounts on Anemia Drug
New York Times, NY
Thursday, August 28, 2008 - 8:00am
tags:
CROs: The 'Big Pharma Effect'
Seeking Alpha
Thursday, August 28, 2008 - 7:58am
tags:
Amgen to discontinue discounts on anemia drug: report
Yahoo/Reuters
Thursday, August 28, 2008 - 6:33am
tags:
Boehringer Drugs Disappoint in Company-Sponsored Stroke Study
Bloomberg
Thursday, August 28, 2008 - 6:32am
tags:
UCB Cuts 2,000 Jobs to Spur Profit; Shares Decline
Bloomberg
Thursday, August 28, 2008 - 6:32am
tags:
Cell Genesys' Saving Grace
Forbes
Wednesday, August 27, 2008 - 10:30pm
tags:
Takeda's Velcade Found Better Than Standard Blood-Cancer Drug
Bloomberg
Wednesday, August 27, 2008 - 10:28pm
tags:
Efficacy Questions Still Dog Vytorin
Forbes
Wednesday, August 27, 2008 - 10:27pm
tags:
Rough Road Ahead For Byetta
Forbes
Wednesday, August 27, 2008 - 10:24pm
tags:
Vioxx settlement judge caps legal fees at 32 pct
Yahoo/AP
Wednesday, August 27, 2008 - 4:41pm
tags:
King Pharma a Hold, Pre-Acquisition
Yahoo/Zacks.com
Wednesday, August 27, 2008 - 4:26pm
tags:
Grim Reaper Hurts Cell Genesys
Forbes
Wednesday, August 27, 2008 - 4:25pm
tags:
Another Storm Brewing For Vytorin
Forbes
Wednesday, August 27, 2008 - 4:23pm
tags:
Amylin, Lilly: Another Case of a Panic Driven Sell-Off
Seeking Alpha
Wednesday, August 27, 2008 - 4:20pm
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline
The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline
The Current Environment
In the Pipeline
Informa Connect's Patient Assistance & Access Programs (PAP)
Drug Channels
2025 Brand Drug Challenges: A GoodRx Perspective
Drug Channels
Snake Antivenoms, Computed
In the Pipeline

Latest Jobs

Pharmaceutical Sales Representative - Associate Territory Manager, Cardiometabolic Health
Tuscaloosa, Alabama
Eli Lilly and Company
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, US
Lundbeck
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, 17602
Lundbeck
Account Executive - Women's Health - W Palm Beach
Salt Lake City, Utah, 84101
Myriad Genetics
Pharmaceutical Sales Rep- Associate Territory Manager- Cardiometabolic Health
Tallahassee, Florida
Eli Lilly and Company
Psychiatry Account Manager - Atlanta East / Augusta, GA
Augusta, Georgia, US
Lundbeck
Sr. Training Manager Learning & Performance- Commercial Sales
Yardley, Pennsylvania, United States
EVERSANA
Psychiatry Account Manager - Billings, MT
Billings, Montana, US
Lundbeck
Neuroscience Account Manager - Indianapolis, IN
Indianapolis, Indiana, US
Lundbeck
Hybrid Pharmaceutical Sales Representative- EST/CST
Kansas City, Kansas, 66101
Amplity Health
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information